Bristol-Myers Is For Sale
Bristol-Myers Squibb, the $20 billion (sales) pharmaceutical giant, has put itself up for sale, according to a news report from Reuters. Itself a product of the 1989 merger of Bristol-Myers and Squibb Corporation, the company is said to be examining a number of options, including a possible combination with GlaxoSmithKline.
Click here to read the Reuters report.
Want to use this article? Click here for options!
© 2010 Penton Media Inc.
Acceptable Use Policy blog comments powered by Disqus
Advertisement
Advertisement
Social Media
Meetings Collaborative
Rate your experience with meeting venues and suppliers.
| Powered by: Meetings Collaborative | |
Apex Webinars
Demonstrating Leadership in Turbulent Times
Join MeetingsNet, the Convention Industry Council, and two meeting professionals to learn how seeking out professional development and volunteer opportunities can enhance your career advancement. Click here for free registration.
View it Now! | View APEX Archives
Webinars
Association Day: How to Plan a Winning International Meeting
Join MeetingsNet for two webinars for association professionals taking meetings outside the U.S., featuring expert panelists covering topics from launching your first international meeting to budgeting, sponsorship, and negotiations.
View on Demand | View Archived Webinars
Advertisement
